BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15352159)

  • 21. Full body: the importance of the phenotype in evolution.
    Kampis G; Gulyás L
    Artif Life; 2008; 14(3):375-86. PubMed ID: 18489249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistep skin cancer in mice as a model to study the evolution of cancer cells.
    Kemp CJ
    Semin Cancer Biol; 2005 Dec; 15(6):460-73. PubMed ID: 16039870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer selection as a source of developmental and evolutionary constraints.
    Galis F; Metz JA
    Bioessays; 2003 Nov; 25(11):1035-9. PubMed ID: 14579244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The topology of the possible: formal spaces underlying patterns of evolutionary change.
    Stadler BM; Stadler PF; Wagner GP; Fontana W
    J Theor Biol; 2001 Nov; 213(2):241-74. PubMed ID: 11894994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problems in the morphological assessment of the degree of tumor malignancy].
    Kats VA
    Arkh Patol; 1989; 51(12):69-72. PubMed ID: 2629668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
    Worsham MJ; Pals G; Schouten JP; Miller F; Tiwari N; van Spaendonk R; Wolman SR
    Breast Cancer Res Treat; 2006 Mar; 96(2):177-86. PubMed ID: 16319984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational analysis of the influence of the microenvironment on carcinogenesis.
    Basanta D; Ribba B; Watkin E; You B; Deutsch A
    Math Biosci; 2011 Jan; 229(1):22-9. PubMed ID: 21044636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
    Melchor L; Benítez J
    Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical model of breast cancer development, local treatment and recurrence.
    Enderling H; Chaplain MA; Anderson AR; Vaidya JS
    J Theor Biol; 2007 May; 246(2):245-59. PubMed ID: 17289081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term evolution of multilocus traits under frequency-dependent disruptive selection.
    van Doorn GS; Dieckmann U
    Evolution; 2006 Nov; 60(11):2226-38. PubMed ID: 17236416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation: an encouraging approach to anticancer therapy.
    Marchal JA; Rodríguez-Serrano F; Campos J; Madeddu R; Boulaiz H; Martínez-Amat A; Carrillo E; Caba O; Prados JC; Vélez C; Melguizo C; Montella A; Aránega A
    Ital J Anat Embryol; 2006; 111(1):45-64. PubMed ID: 16736717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concepts of molecular biology on gastric carcinogenesis.
    Kountouras J; Zavos C; Chatzopoulos D
    Hepatogastroenterology; 2005; 52(64):1305-12. PubMed ID: 16001683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stochastic model of cancer initiation including a bystander effect.
    Østby I; Øyehaug L; Steen HB
    J Theor Biol; 2006 Aug; 241(4):751-64. PubMed ID: 16499930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Models of tumor-host interaction as competing populations: implications for tumor biology and treatment.
    Gatenby RA
    J Theor Biol; 1995 Oct; 176(4):447-55. PubMed ID: 8551743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species.
    Parris GE
    Med Hypotheses; 2005; 65(5):846-50. PubMed ID: 16023792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mutation matrix and the evolution of evolvability.
    Jones AG; Arnold SJ; Bürger R
    Evolution; 2007 Apr; 61(4):727-45. PubMed ID: 17439608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.